-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $84

Benzinga·05/02/2025 16:15:46
Listen to the news
Guggenheim analyst Eddie Hickman maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from $78 to $84.